Verrica Pharmaceuticals, Inc. (VRCA)
4.11
-0.07
(-1.67%)
USD |
NASDAQ |
Oct 09, 16:00
4.10
-0.01
(-0.24%)
After-Hours: 20:00
Verrica Pharmaceuticals Price to Book Value : 16.39 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 16.39 |
| October 08, 2026 | 16.67 |
| October 07, 2026 | 16.51 |
| October 06, 2026 | 16.79 |
| October 05, 2026 | 17.19 |
| October 02, 2026 | 17.47 |
| October 01, 2026 | 18.01 |
| September 30, 2026 | 19.12 |
| September 29, 2026 | 17.79 |
| September 28, 2026 | 18.35 |
| September 25, 2026 | 17.43 |
| September 24, 2026 | 17.39 |
| September 23, 2026 | 18.43 |
| September 22, 2026 | 18.83 |
| September 21, 2026 | 17.91 |
| September 18, 2026 | 17.75 |
| September 17, 2026 | 18.55 |
| September 16, 2026 | 18.07 |
| September 15, 2026 | 18.27 |
| September 14, 2026 | 19.06 |
| September 11, 2026 | 19.58 |
| September 10, 2026 | 19.74 |
| September 09, 2026 | 20.18 |
| September 08, 2026 | 20.98 |
| September 04, 2026 | 21.14 |
| Date | Value |
|---|---|
| September 03, 2026 | 21.38 |
| September 02, 2026 | 21.50 |
| September 01, 2026 | 20.90 |
| August 31, 2026 | 21.78 |
| August 28, 2026 | 22.69 |
| August 27, 2026 | 20.22 |
| August 26, 2026 | 19.58 |
| August 25, 2026 | 19.70 |
| August 24, 2026 | 19.42 |
| August 21, 2026 | 19.22 |
| August 20, 2026 | 19.38 |
| August 19, 2026 | 19.90 |
| August 18, 2026 | 18.67 |
| August 17, 2026 | 19.50 |
| August 14, 2026 | 19.82 |
| August 13, 2026 | 19.38 |
| August 12, 2026 | 20.30 |
| August 11, 2026 | 20.82 |
| August 10, 2026 | 20.42 |
| August 07, 2026 | 20.26 |
| August 06, 2026 | 21.38 |
| August 05, 2026 | 21.98 |
| August 04, 2026 | 21.58 |
| August 03, 2026 | 20.94 |
| July 31, 2026 | 20.82 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.842 |
| Corcept Therapeutics, Inc. | 18.53 |
| Veru, Inc. | 1.478 |
| Johnson & Johnson | 7.410 |
| Eli Lilly & Co. | 32.77 |
Price to Book Value Related Metrics
| PS Ratio | 2.244 |
| Price | 4.11 |
| Earnings Yield | -40.70% |
| Market Cap | 70.60M |